Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Molecular Therapy. Nucleic Acids
|
August 30, 2021
A non-viral and selection-free <i>COL7A1</i> HDR approach with improved safety profile for dystrophic epidermolysis bullosa
Thomas Kocher, Johannes Bischof, Simone Alexandra Haas, et al.
The Journal of Dermatology
|
January 24, 2025
Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression
Sonja Dorfer, Michael Ablinger, Monika Wimmer, et al.
Cancer Letters
|
July 1, 2018
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology
Yuchen Sun, Josefina Piñón Hofbauer, Manami Harada, et al.
Frontiers in Medicine
|
September 12, 2022
<i>COL17A1</i> editing <i>via</i> homology-directed repair in junctional epidermolysis bullosa
Igor Petković, Johannes Bischof, Thomas Kocher, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
Michael Ablinger, Thomas Lettner, Nicole Friedl, et al.
The Journal of Investigative Dermatology
|
September 18, 2020
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study
Olivier Bornert, Marieke Hogervorst, Pauline Nauroy, et al.
The British Journal of Dermatology
|
September 8, 2023
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
Julia Illmer, Roland Zauner, Josefina Piñón Hofbauer, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA <i>trans</i>-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Katharina Woess, Yuchen Sun, Hanae Morio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
Johannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa
Markus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Molecular Therapy. Nucleic Acids
|
August 30, 2021
A non-viral and selection-free <i>COL7A1</i> HDR approach with improved safety profile for dystrophic epidermolysis bullosa
Thomas Kocher, Johannes Bischof, Simone Alexandra Haas, et al.
The Journal of Dermatology
|
January 24, 2025
Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression
Sonja Dorfer, Michael Ablinger, Monika Wimmer, et al.
Cancer Letters
|
July 1, 2018
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology
Yuchen Sun, Josefina Piñón Hofbauer, Manami Harada, et al.
Frontiers in Medicine
|
September 12, 2022
<i>COL17A1</i> editing <i>via</i> homology-directed repair in junctional epidermolysis bullosa
Igor Petković, Johannes Bischof, Thomas Kocher, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
Michael Ablinger, Thomas Lettner, Nicole Friedl, et al.
The Journal of Investigative Dermatology
|
September 18, 2020
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study
Olivier Bornert, Marieke Hogervorst, Pauline Nauroy, et al.
The British Journal of Dermatology
|
September 8, 2023
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
Julia Illmer, Roland Zauner, Josefina Piñón Hofbauer, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA <i>trans</i>-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Katharina Woess, Yuchen Sun, Hanae Morio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
Johannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa
Markus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Page
of 8